Health Encyclopedia

 

Document Search by P00719



Prostate CancerCáncer de la Próstata

Prostate Cancer

Prostate cancer statistics

The fear of having prostate cancer can be devastating to men. However, it is most successfully treated when found early. Consider these statistics from the American Cancer Society (ACS):

  • More than 90 percent of all prostate cancers are discovered while they are either localized (confined to the prostate) or regional (nearby). The five-year survival rate for men diagnosed with prostate tumors discovered at these stages is nearly 100 percent.

  • In the past 25 years, the five-year survival rate for all stages combined has increased from 68 to nearly 100 percent.

  • Prostate cancer is the most common cancer among men, excluding skin cancer.

  • For 2012, the ACS estimates 241,740 new cases of prostate cancer will be diagnosed in the U.S.

  • Year 2012 estimates also include 28,170 deaths occurring from prostate cancer in the U.S. alone, making it the second leading cause of cancer death in men.

Illustration of  the anatomy of the male reproductive tract
Click Image to Enlarge

Facts about the prostate gland

The prostate is a sex gland in men. It is about the size of a walnut, although it can grow larger, and surrounds the neck of the bladder and urethra—the tube that carries urine from the bladder. The prostate is partly muscular and partly glandular, with ducts opening into the prostatic portion of the urethra. It is made up of three lobes: a center lobe with one lobe on each side.

The prostate gland secretes a slightly alkaline fluid that forms part of the seminal fluid, a fluid that carries sperm.

What are the symptoms of prostate cancer?

There are usually no specific signs or symptoms of early prostate cancer. A prostate-specific antigen (PSA) blood test and digital rectal exam (DRE) can provide the best chance of identifying prostate cancer in its earliest stages, but these tests can have drawbacks. Talk to your doctor about whether prostate cancer screening is right for you.

The following are the most common symptoms of prostate cancer. However, each individual may experience symptoms differently. Symptoms may include:

  • Weak or interrupted flow of urine

  • Urinating often (especially at night)

  • Difficulty urinating or holding back urine

  • Inability to urinate

  • Pain or burning when urinating

  • Blood in the urine or semen

  • Nagging pain in the back, hips, or pelvis because cancer has spread to the bones 

  • Painful ejaculation

The symptoms of prostate cancer may resemble other conditions or medical problems. Always consult your doctor for a diagnosis.

As a man gets older, his prostate may grow bigger and obstruct the flow of urine, or interfere with sexual function. An enlarged prostate gland—a condition called benign prostate hyperplasiamay require treatment with medicine or surgery to relieve symptoms. This common benign prostate condition, which is not cancer, can cause many of the same symptoms as prostate cancer.

What are risk factors for prostate cancer?

In general, all men are at risk for prostate cancer. However, there are specific risk factors that increase the likelihood that certain men will develop the disease, including the following:

  • Age. Age is a risk factor for prostate cancer, especially for men 50 and older. Nearly two-thirds of all prostate cancers are diagnosed in men over the age of 65.

  • Race. Prostate cancer is more common among African-American men than it is among white American men. Japanese and Chinese men native to their country have the lowest rates of prostate cancer. However, when Chinese and Japanese men immigrate to the U.S., they have an increased risk of and mortality rate from prostate cancer when compared to their native populations. In Japan, the incidence of prostate cancer has increased as Western diets and lifestyles have been adopted.

  • Diet. Epidemiological data suggest that the diet consumed in Western industrialized countries may be a factor in developing prostate cancer. Consider the following information regarding diet and its effect on the risk for prostate cancer:

    • Fat. Some studies suggest that men who eat a high-fat diet, especially if it is high in red meat or high-fat dairy products, may have a greater chance of developing prostate cancer.

    • Fruits and vegetables. Diets high in fruits and vegetables may lower prostate cancer risk, although it is not clear which nutrient(s) may be responsible for this. 

    • Vitamin E and selenium. The antioxidant Vitamin E, combined with selenium, has been shown to inhibit tumor growth in laboratory animals. But a large study found that supplements of these substances did not lower the risk of prostate cancer in men. In fact, the men taking vitamin E had a slightly higher risk of prostate cancer. 

    • Carotenoids. Carotenoids, such as lycopenes, have been shown to inhibit the growth of human prostate cancer cells in tissue cultures (cells grown in the laboratory). The primary source of lycopenes is processed tomatoes. Again, however, it is not clear if lycopenes affect prostate cancer risk in men, as not all studies have found a benefit.

  • Obesity. Most studies have not found obesity to affect the risk of getting prostate cancer, but obese men may be more likely to develop more aggressive forms of prostate cancer.

  • Environmental exposures. Some studies show an increased risk of prostate cancer in men who are farmers, or those exposed to the metal cadmium while making batteries, welding, or electroplating. Additional research is needed in this area to confirm whether this is a true association.

  • Having a vasectomy, BPH (benign prostatic hyperplasia), or an STD (sexually transmitted disease). Researchers have looked at whether men who have had a vasectomy, BPH, or those who have been exposed to a sexually transmitted disease are at increased risk for prostate cancer. Some studies suggest a link, while others do not support these claims.

  • Family history of prostate cancer. Having a father or brother with prostate cancer more than doubles a man's risk of developing this disease. The risk is even higher for men with several affected relatives, particularly if the relatives were young at the time of diagnosis. Geneticists (doctors and scientists who study inheritance and the causes of genetic disease) divide families into three groups, depending on the number of men with prostate cancer and their ages of onset, including the following:

    • Sporadic. A family with prostate cancer present in one man, at a typical age of onset; sporadic means occurs by chance.

    • Familial. A family with prostate cancer present in more than one person, but with no definitive pattern of inheritance and usually an older age of onset.

    • Hereditary. A family with a cluster of three or more affected relatives within any nuclear family (parents and their children), a family with prostate cancer in each of three generations on either the mother or father's side, or a cluster of two relatives affected at a young age (55 or younger). Five to 10 percent of prostate cancer cases are considered hereditary.

  • Genetic factors. In the center of each cell of the human body, our genetic material—chromosomes—are found. Normally, cells contain 46 chromosomes, or 23 pairs, half of which are inherited from our mother, half from our father. The chromosomes contain genes—the body's blueprint. Genes code for traits, such as eye color and blood type, and also control important regulatory functions in the body such as the rate of cell growth. Some genes, when altered or mutated, give a higher risk for uncontrolled cell growth, which, in turn, can lead to tumor development. These genes have various names, but overall are referred to as cancer susceptibility genes. Approximately five to 10 percent of all prostate cancers are known to be attributed to an inherited DNA change.

Procedures used to evaluate prostate problems

In addition to regular physical examinations that may include blood, urine, and possibly other laboratory tests, many groups, such as the American Cancer Society, suggest talking to your doctor to learn more about the pros and cons of screening for prostate cancer to help you decide if it is right for you. Other expert groups have different recommendations. For example, the U.S. Preventive Services Task Force recommends against routine prostate cancer screening because the task force believes the benefit does not outweigh the harm. The tests used for screening include:

  • DRE (digital rectal examinations). The doctor places a gloved and lubricated finger into the rectum to examine the rectum and feel the prostate gland. DREs may be conducted annually for men over the age of 50 who choose to be screened. Men in high-risk groups, such as African-Americans, or those with a strong family history of prostate cancer, should consult their doctors about being tested at age 45.

  • PSA (prostate-specific antigen). PSA is a substance produced by the prostate gland, which may be found in higher amounts in the blood of men who have prostate cancer. PSA tests may be done annually for men over the age of 50 who choose to be tested. Men in high-risk groups, such as African-Americans, or those with a strong family history of prostate cancer, should consult their doctors about being tested at an earlier age.

What are some other prostate cancer evaluation procedures?

If the DRE or PSA results are unusual, your doctor may repeat the tests or request other procedures. These evaluation tools may include:

  • Prostate biopsy. A test where the doctor inserts thin, hollow needles into the prostate to get samples for examination under a microscope to determine if cancer cells are present.

  • Transrectal ultrasound (TRUS). A test using sound wave echoes to create an image of the prostate gland to visually inspect for abnormal conditions such as gland enlargement, nodules, penetration of tumor through capsule of the gland, and/or invasion of seminal vesicles; may also be used for guidance of needle biopsies of the prostate gland and/or guiding the nitrogen probes in cryosurgery.

  • Computed tomography scan (also called a CT or CAT scan). A diagnostic imaging procedure that uses a combination of X-rays and computer technology to produce horizontal, or axial, images (often called slices) of the body. A CT scan shows detailed images of any part of the body, including the bones, muscles, fat, and organs. CT scans are more detailed than general X-rays.

  • Magnetic resonance imaging (MRI). A diagnostic procedure that uses a combination of large magnets, radiofrequencies, and a computer to produce detailed images of organs and structures within the body.

  • Radionuclide bone scan. A nuclear imaging method that helps to show whether the cancer has spread from the prostate gland to the bones. The procedure involves an injection of radioactive material that helps to locate diseased bone cells throughout the entire body, suggesting possible metastatic cancer.

  • Lymph node biopsy. A procedure in which tissue samples are removed (with a needle or during surgery) from the lymph nodes for examination under a microscope to determine if cancer or other abnormal cells are present.

The diagnosis of cancer is confirmed only by a biopsy.

 
Related Items
Wellness Library
  What Do You Know About Prostate Health?
SCC Videos
  Prostate Cancer
Content Type 134
  How Lifestyle and Medical History Affect Cancer Risk: Facts for Gay and Bisexual Men
  Top 10 Cancers Among Men
Content Type 167
  Prostate-Specific Antigen
Nutritional Supplement Advisor
  Selenium
Drug Reference
  Estramustine
  Estradiol
  Histrelin
  Diethylstilbestrol, DES
  Triptorelin
  Flutamide
  Abarelix
  Goserelin
  Leuprolide
  Sipuleucel-T
  Degarelix
  Mitoxantrone
  Vinblastine
  Bicalutamide
  Nilutamide
Cancer Source
  Statistics About Prostate Cancer
  Am I At Risk for Prostate Cancer?
  What Are the Symptoms of Prostate Cancer?
  Understanding Your Stage of Prostate Cancer
  How Does My Doctor Know I Have Prostate Cancer?
  Tests That Help Evaluate Prostate Cancer
  Understanding the Gleason Score and Your Grade of Prostate Cancer
  Prostate Cancer Treatment Introduction
  The Goal of Radiation Therapy for Prostate Cancer
  Prostate Cancer Vaccines
  Prostate Cancer and PSA Screening
  What Happens During Internal Radiation Therapy (Brachytherapy) for Prostate Cancer
  Prostate Cancer: Diet and Prevention
  Dealing with Erectile Dysfunction
  Prostate Cancer: The Role of Tomatoes in Prevention
  Osteoporosis in Men with Cancer
  I've Just Been Told I Have Prostate Cancer
  What to Know About Your Treatment Choices for Prostate Cancer
  What to Know About Surgery for Prostate Cancer
  What to Know About Hormone Therapy for Prostate Cancer
  What to Know About Combination Therapy for Prostate Cancer
  How Your Doctor Uses Biopsies to Diagnose Prostate Cancer
  What You Need to Know About PIN
  Can I Survive Prostate Cancer? What Is My Prognosis?
  Tell Your Healthcare Team How You Feel During Treatment for Prostate Cancer
  Do What You Can to Ease Side Effects of Treatment for Advanced Prostate Cancer
  What Happens During External Beam Radiation Treatment for Prostate Cancer
  What to Expect After External Radiation Therapy for Prostate Cancer
  Treatment Options for Local Prostate Cancer
  What to Expect After Internal Radiation (Brachytherapy) Treatment for Prostate Cancer
  What Happens During Hormone Treatment for Prostate Cancer
  What to Expect After Hormone Treatment for Prostate Cancer
  Goal of Chemotherapy for Prostate Cancer
  What Happens During Chemotherapy for Prostate Cancer
  What to Expect After Chemotherapy for Prostate Cancer
  Treatment Options for Metastatic or Advanced Prostate Cancer
  Questions to Ask About Treatment for Prostate Cancer
  What to Know About Lymph Node Biopsies: How to Tell if Prostate Cancer Has Spread
  FDA-Approved Drugs
Cancer FAQs
  Prostate Cancer FAQ
Quizzes
  Reproductive Cancers Quiz
Daily News Feed
  Kidney Failure a Possible Risk of Prostate Cancer Hormone Treatment: Study
  New Drug May Extend Survival for Some Prostate Cancer Patients
  Helping Men Resolve Conflicts About Prostate Cancer Screening
  Experts Call for Redefinition of 'Cancer'
  High-Tech Prostate Scan May Boost Cancer Detection
  Metformin May Lower Risk of Prostate Cancer Death, Researchers Say
  'Watch & Wait' OK for Many Low-Grade Prostate Tumors: Study
  18-Year Study Finds Drug Cut Prostate Cancer Risk
  Could Heavy Coffee Drinking Help Men Battle Prostate Cancer?
  Gene Test May Help Predict Prostate Cancer Aggressiveness
  Extended Hormone Therapy Doesn't Help Some Prostate Cancer Patients: Study
  Usual 'Hot Flash' Therapies Don't Help Prostate Cancer Patients: Study
  Older Men Gain Little From PSA Test: Study
  Radiation Therapy Overused in Advanced Prostate Cancer, Study Says
  Study Ties Y Chromosome Variations to Prostate Cancer Risk
  Blood Test Shows Promise for Cancer Detection, Study Finds
  Many Doctors Ignore Guidelines, Order PSA Tests for Elderly Men
  Prostate Biopsies May Cause Unnecessary Worry for Many Men, Study Finds
  Do Some Docs Have Vested Interest in Prescribing Radiation for Prostate Cancer?
  Tests May Someday Show Which Breast, Prostate Cancers Will Turn Aggressive
  Overweight Men May Face Higher Death Risk From Prostate Cancer: Study
  Statin Use Linked to Lower Prostate Cancer Death Risk
  History of Prostate Cancer Tied to Higher Odds for Melanoma
  Type of Surgical Anesthesia Might Influence Prostate Cancer's Return
  U.S. Cancer Death Rates Continue to Decline: Report
  Mouse Study Hints at Plastics Chemical's Link to Prostate Cancer Risk
  U.S. Cancer Deaths Decline Again: Report
  Scientists Explore Effect of Exercise on Prostate Cancer Patients
  Progress Against Cancer May Be Greater Than Thought
  'Sleep Hormone' Tied to Possible Lower Prostate Cancer Risk
  Drug May Extend Survival for Men With Advanced Prostate Cancer
  Vitamin E, Selenium Supplements Might Double Chances of Prostate Cancer
  Surgery May Benefit Younger Prostate Cancer Patients
  New Therapy May Shrink Enlarged Prostate With Fewer Side Effects: Study
  Newer Radiation Therapy Treats Prostate Cancer More Quickly: Study
  Slight Drop in Rate of Advanced Cancers, CDC Says
  Cialis May Not Prevent Impotence in Men Treated for Prostate Cancer
  DNA Test May Gauge Risk of Prostate Cancer's Return
  Quarter of Prostate Cancer Patients May Abandon 'Watchful Waiting' Approach
  Low Vitamin D Linked to Aggressive, Advanced Prostate Cancers: Study
  Some Prostate Cancer Patients Might Safely Delay Hormonal Therapy: Study
  Dogs May Help Spot Human Prostate Cancers, Study Finds
  Diet, Lifestyle Affect Prostate Cancer Risk, Studies Find
  New Approach May Boost Survival From Advanced Prostate Cancer
  New Drug May Boost Survival for Advanced Prostate Cancer Patients: Study
  Cost of Prostate Cancer Surgery Varies Widely in U.S.
  Study Links Vasectomy to Aggressive Prostate Cancer
  Depression May Make It Harder to Beat Prostate Cancer
Adult Diseases and Conditions
  Prostate Cancer in African-American Men
  Angiogenesis Inhibitors
  Clinical Trials for Prostate Cancer
  Coping with Prostate Cancer
  For Family Members Coping with Prostate Cancer
  Grading of Prostate Cancer
  Herbal Remedies For Prostate Cancer
  Home Page - Prostate Health
  Chemotherapy for Prostate Cancer
  Expectant Therapy
  Hormone Therapy for Prostate Cancer
  Radiation Therapy
  Diagnostic and Evaluation Procedures for Prostate Cancer
  Risk Factors for Prostate Cancer
  Prostate Cancer Index
  Psychosocial Factors
  Treatments for Prostate Cancer
  Signs and Symptoms of Prostate Cancer
  Staging of Prostate Cancer
  Surgery for Prostate Cancer
  Prostate Cancer Overview
Test and Procedures
  Prostate Biopsy